Manchester researchers tested AI-designed enzymes for one reaction relevant to lenacapavir synthesis. The preprint reports laboratory activity, not a finished manufacturing process or a clinical advance.
LanthaGen Bio’s £100,000 equity award will support research into an unnamed metal and extend scientists’ contracts, according to the University of Manchester.
With your permission, Google Analytics helps us understand how visitors use this website. Google receives usage and device information. Analytics stays off unless you accept. We remember your choice for six months.
This choice covers Google Analytics. You can change it at any time in Privacy settings. Privacy Policy